Rapid on-site testing Ativa Medical enables on-site diagnostic tests with a single drop of blood, reducing time to results and eliminating lab send-outs. This creates a compelling pitch for healthcare facilities seeking faster decision-making and lower sample handling costs.

Comprehensive point-of-care Their system claims to perform major tests at the point of care with broad capabilities and a universal operating system, presenting an opportunity to target clinics and hospitals seeking to replace multiple vendors with a single, integrated solution.

Patented technology With over 200 patents behind the platform, Ativa can leverage defensible technology upgrades and higher switching costs to position the product as a long-term diagnostic solution, appealing to procurement teams prioritizing innovation.

Mid-market focus Revenue range and employee count place Ativa in the small to mid-sized medtech segment, suggesting sales motions centered on ambulatory centers, community hospitals, and regional health systems that value speed and cost savings.

Funding and growth A mixed funding profile and a $1M-$10M revenue band indicate traction with investors and potential for accelerated sales cycles through scalable deployments, partnerships, or pilot programs with larger healthcare providers.